Unaudited Condensed Consolidated Statements Of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021		24,592,098
Beginning balance at Dec. 31, 2021	$ 1,713,990	$ 246	$ 1,529,969	$ 174,572	$ 9,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,068		5,068	0
Issuance of restricted stock, net (in shares)		437,946
Issuance of restricted stock, net	(2,744)	$ 5	(2,749)
Repurchase of common stock (in shares)		(66,502)
Repurchase of common stock	(3,961)	$ (1)	(3,960)	0
Common stock dividends	(15,051)			(15,051)
Foreign currency translation adjustment	20,499				20,499
Unrealized (losses) gains on marketable securities, net of tax	(517)				(517)
Net income (loss)	7,029			7,029
Ending balance (in shares) at Mar. 31, 2022		24,963,542
Ending balance at Mar. 31, 2022	1,724,313	$ 250	1,528,328	166,550	29,185
Beginning balance (in shares) at Dec. 31, 2022		24,402,891
Beginning balance at Dec. 31, 2022	1,635,790	$ 244	1,510,924	159,690	(35,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,632		5,632	0
Exercise of stock options, net (in shares)		1,322
Exercise of stock options, net	55		55
Issuance of restricted stock, net (in shares)		187,162
Issuance of restricted stock, net	(5,019)	$ 2	(5,021)
Common stock dividends	(14,769)			(14,769)
Foreign currency translation adjustment	(9,340)				(9,340)
Unrealized (losses) gains on marketable securities, net of tax	108				108
Net income (loss)	(2,028)			(2,028)
Ending balance (in shares) at Mar. 31, 2023		24,591,375
Ending balance at Mar. 31, 2023	$ 1,610,429	$ 246	$ 1,511,590	$ 142,893	$ (44,300)